US Pharma MarketingAstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel
Europe Channels All News In Focus Special AI Bioregnum Biotech Voices Cell/Gene Tx China Coronavirus Deals Diagnostics Discovery FDA+ Financing Health Tech Law Letters to the Editor Manufacturing Marketing Nikkei Biotechnology Opinion Outsourcing Peer Review People Pharma R&D Startups Weekly Webinars Signal More Work at Endpoints Biopharma Jobs Letter to Editors Editorial Standards IPO Tracker Webinars Events Sponsored Posts Advertise Privacy Policy Endpoints Merch About Us Help SIGN UP LOG IN May 22, 2026 12:47 PM EDT Pharma As­traZeneca wins EU back­ing for breast can­cer drug, split­ting with FDA pan­el Anna Brown News Reporter An As­traZeneca breast can­cer drug re­ceived…
An AstraZeneca breast cancer drug received a positive opinion from European regulators, despite an FDA advisory committee voting against the drug last month. Novo Nordisk’s Wegovy pill also got the EU go-ahead.
The European Medicines ...
Source: Endpoints News